ADMA

ADMA Biologics, Inc.

Contracts

Total Value

Stock Metrics

9.7%

Short % Float

8.8d to cover · Moderate squeeze

93.3%

Inst % Float

10 holders · 2026-06-30

Blackrock Inc.

Top Holder

17.1% of float

226.7M sh

Public Float

23/100

Dilution Score

Low

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

23/100

LOW

Inst: 93.3% · Top: Blackrock Inc.

Biotech Analytics

Plasma Therapeutics

6.29

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk23

Clinical Trials0

Short Interest30